Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce ...

GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

A new nasal vaccine may help reduce the spread of whooping cough, a highly contagious respiratory disease that has been ...

Japan’s MHLW grants expanded indication approval to GSK’s RSV vaccine, Arexvy for adults aged 50-59 at increased risk of severe RSV disease: London, UK Saturday, November 23, ...

A phase 1 trial of α-lactalbumin vaccine for the treatment of patients with triple-negative breast cancer demonstrated safety ...

Phase 1 trial demonstrates safety and effectiveness of neoantigen DNA vaccines in triple-negative breast cancer, achieving 87.5% recurrence-free survival at 36 months.

After decades of disappointment, efforts to create jabs that can stimulate the immune system to fight cancer are showing ...

New Nasal Vaccine May Reduce Whooping Cough SpreadA new nasal vaccine developed by Tulane University may hold the key to ...

Current pertussis vaccines are widely used and effective at preventing whooping cough, caused by the Bordetella pertussis ...

A new nasal whooping cough vaccine showed an ability to prevent both infection and transmission of the disease in mice. Current vaccines offer treatment but fail to halt transmission of the bacteria ...

Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology IndustriesFAYETTEVILLE, Ark., Nov.